These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1194 related items for PubMed ID: 17668556

  • 21. Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.
    Netter HJ, Woo WP, Tindle R, Macfarlan RI, Gowans EJ.
    Vaccine; 2003 Jun 20; 21(21-22):2692-7. PubMed ID: 12798605
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A, Schreier E, Roggendorf M.
    Virology; 1995 Apr 20; 208(2):653-61. PubMed ID: 7538251
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Skrastina D, Bulavaite A, Sominskaya I, Kovalevska L, Ose V, Priede D, Pumpens P, Sasnauskas K.
    Vaccine; 2008 Apr 07; 26(16):1972-81. PubMed ID: 18343539
    [Abstract] [Full Text] [Related]

  • 28. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S, Rispeter K, Meisel H, Kraas W, Jung G, Roggendorf M, Zibert A.
    Virology; 1998 Apr 10; 243(2):313-21. PubMed ID: 9568031
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
    Czarnota A, Tyborowska J, Peszyńska-Sularz G, Gromadzka B, Bieńkowska-Szewczyk K, Grzyb K.
    Microb Cell Fact; 2016 Apr 13; 15():62. PubMed ID: 27075377
    [Abstract] [Full Text] [Related]

  • 31. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
    Akazawa D, Moriyama M, Yokokawa H, Omi N, Watanabe N, Date T, Morikawa K, Aizaki H, Ishii K, Kato T, Mochizuki H, Nakamura N, Wakita T.
    Gastroenterology; 2013 Aug 13; 145(2):447-55.e1-4. PubMed ID: 23673355
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Study of neutralization antibodie induced by DNA vaccine of HCV envelope protein 2 in mice].
    Shao S, Zhou H, Tong Y, Ren Y, Chen Z.
    Wei Sheng Yan Jiu; 2011 May 13; 40(3):295-8. PubMed ID: 21695897
    [Abstract] [Full Text] [Related]

  • 34. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S, Roccasecca R, Meola A, Ercole BB, Tafi R, Dubuisson J, Galfré G, Cortese R, Nicosia A.
    Hepatology; 2001 Mar 13; 33(3):692-703. PubMed ID: 11230750
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9.
    Uhde-Holzem K, Schlösser V, Viazov S, Fischer R, Commandeur U.
    J Virol Methods; 2010 Jun 13; 166(1-2):12-20. PubMed ID: 20138085
    [Abstract] [Full Text] [Related]

  • 37. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.
    Desjardins D, Huret C, Dalba C, Kreppel F, Kochanek S, Cosset FL, Tangy F, Klatzmann D, Bellier B.
    J Gene Med; 2009 Apr 13; 11(4):313-25. PubMed ID: 19248137
    [Abstract] [Full Text] [Related]

  • 38. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
    Mihailova M, Boos M, Petrovskis I, Ose V, Skrastina D, Fiedler M, Sominskaya I, Ross S, Pumpens P, Roggendorf M, Viazov S.
    Vaccine; 2006 May 15; 24(20):4369-77. PubMed ID: 16574285
    [Abstract] [Full Text] [Related]

  • 39. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J, Radunz W, Eisenbach C, Geib J, Gehrke S, Pfaff E, Stremmel W.
    Eur J Clin Invest; 2007 May 15; 37(5):396-406. PubMed ID: 17461986
    [Abstract] [Full Text] [Related]

  • 40. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U, Tyagi P, Swaminathan S, Khanna N.
    Vaccine; 2013 Jan 30; 31(6):873-8. PubMed ID: 23261049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.